These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2540559)

  • 1. Use of cytomegalovirus-seropositive donor kidneys in seronegative patients: results of prospective serotesting and matching in one center.
    Henell KR; Chou S; Norman DJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2082-3. PubMed ID: 2540559
    [No Abstract]   [Full Text] [Related]  

  • 2. [incidence of cytomegalovirus infections following transplantation of kidneys from seropositive and seronegative donors].
    Kaden J; Adamczyk G; Eichler C; Strobelt V; Groth J; Janisch W; May G
    Z Urol Nephrol; 1985 May; 78(5):267-71. PubMed ID: 2994321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patients.
    Kamar N; Mengelle C; Esposito L; Guitard J; Mehrenberger M; Lavayssière L; Ribes D; Cointault O; Durand D; Izopet J; Rostaing L
    J Med Virol; 2008 Jun; 80(6):1012-7. PubMed ID: 18428146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A prospective study of Cytomegalovirus infections in 211 children with renal transplants].
    Cabau N; Gagnadoux MF; Niaudet P; Duros C; Broyer M; Boué A
    Ann Pediatr (Paris); 1983 Jun; 30(6):405-8. PubMed ID: 6309060
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytomegalovirus after heart transplantation. Risk factors for infection and death: a multiinstitutional study. The Cardiac Transplant Research Database Group.
    Kirklin JK; Naftel DC; Levine TB; Bourge RC; Pelletier GB; O'Donnell J; Miller LW; Pritzker MR
    J Heart Lung Transplant; 1994; 13(3):394-404. PubMed ID: 8061014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation.
    Kim CK; Song JH; Kim SM; Peck KR; Oh W; Huh W; Kim YG; Kim SJ; Joh JW; Lee NY; Park CG; Hwang ES; Cha CY; Oh HY
    Transplantation; 2003 Jun; 75(12):2151-5. PubMed ID: 12829929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Lengerke C; Ljubicic T; Meisner C; Loeffler J; Sinzger C; Einsele H; Hebart H
    Bone Marrow Transplant; 2006 Jul; 38(1):53-60. PubMed ID: 16788683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor cytomegalovirus seropositivity and the risk of leukemic relapse after reduced-intensity transplants.
    Nachbaur D; Clausen J; Kircher B
    Eur J Haematol; 2006 May; 76(5):414-9. PubMed ID: 16480430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The source of cytomegalovirus infection in seropositive renal allograft recipients is frequently the donor kidney.
    Grundy JE; Super M; Lui S; Sweny P; Griffiths PD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2126-8. PubMed ID: 2856275
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.
    Peterson PK; Balfour HH; Marker SC; Fryd DS; Howard RJ; Simmons RL
    Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies.
    Iberer F; Halwachs-Baumann G; Rödl S; Pleisnitzer A; Wasler A; Auer T; Petutschnigg B; Müller H; Tscheliessnigg K; Wilders-Truschnig M
    J Heart Lung Transplant; 1994; 13(3):405-11. PubMed ID: 8061015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease.
    Rothenbacher D; Brenner H; Mertens T; Hoffmann MM; Hoffmeister A; Koenig W
    BMC Cardiovasc Disord; 2005 May; 5(1):10. PubMed ID: 15943888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of early cytomegalovirus infection and disease in renal transplant recipients.
    Sagedal S; Hartmann A; Rollag H
    Clin Microbiol Infect; 2005 Jul; 11(7):518-30. PubMed ID: 15966969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of anti-cytomegalovirus IgM in kidney graft recipients.
    Tardy JC; Pouteil-Noble C; Touraine JL; Aymard M
    Transplant Proc; 1987 Oct; 19(5):4066-7. PubMed ID: 2823432
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
    Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N; Holman MJ; Yang HC
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
    Gerna G; Baldanti F; Torsellini M; Minoli L; Viganò M; Oggionnis T; Rampino T; Castiglioni B; Goglio A; Colledan M; Mammana C; Nozza F; Daniele L;
    Antivir Ther; 2007; 12(1):63-72. PubMed ID: 17503749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytomegalovirus: comparative study of diagnostic techniques].
    Yagüe V; Cour I; Kanaan A; Alvarez R; Fernández C; Picazo J; Prats D
    Enferm Infecc Microbiol Clin; 1998 Apr; 16(4):163-8. PubMed ID: 9646559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation.
    Peggs KS; Preiser W; Kottaridis PD; McKeag N; Brink NS; Tedder RS; Goldstone AH; Linch DC; Mackinnon S
    Br J Haematol; 2000 Dec; 111(3):782-90. PubMed ID: 11122138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.